MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis

Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3

(2015) Zhengrong Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNAs as regulators and mediators of c-MYC function

(2015) Rene Jackstadt et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis

(2015) Hyung Seok Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

HDAC2 Provides a Critical Support to Malignant Progression of Hepatocellular Carcinoma through Feedback Control of mTORC1 and AKT

(2014) Ji Heon Noh et al.   CANCER RESEARCH

miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways

(2014) ZHENLIN LIU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3

(2013) Heying Chu et al.   TUMOR BIOLOGY

miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3

(2012) Zhengrong Li et al.   CANCER LETTERS

microRNA involvement in human cancer

(2012) M. V. Iorio et al.   CARCINOGENESIS

MicroRNAs as Diagnostic Biomarkers in Gastric Cancer

(2012) Ying Yin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4

(2012) Jinhai Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Targeted Inactivation of HDAC2 Restores p16INK4a Activity and Exerts Antitumor Effects on Human Gastric Cancer

(2012) J. K. Kim et al.   MOLECULAR CANCER RESEARCH

miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia

(2012) X. Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

microRNAs: Master Regulators as Potential Therapeutics in Cancer

(2011) Michela Garofalo et al.   Annual Review of Pharmacology and Toxicology

Pervasive roles of microRNAs in cardiovascular biology

(2011) Eric M. Small et al.   NATURE

Cancer epigenetics reaches mainstream oncology

(2011) Manuel Rodríguez-Paredes et al.   NATURE MEDICINE

Targeting the epigenome for treatment of cancer

(2011) E-J Geutjes et al.   ONCOGENE

miR-495 is upregulated by E12/E47 in breast cancer stem cells and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1

(2011) W W Hwang-Verslues et al.   ONCOGENE

Targeting microRNAs in cancer: rationale, strategies and challenges

(2010) Ramiro Garzon et al.   NATURE REVIEWS DRUG DISCOVERY

MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells

(2009) Na Xu et al.   CELL

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

(2009) M. Xin et al.   GENES & DEVELOPMENT

An operational definition of epigenetics

(2009) S. L. Berger et al.   GENES & DEVELOPMENT

DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect

(2008) Takayuki Ando et al.   INTERNATIONAL JOURNAL OF CANCER

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

(2008) Désirée Bonci et al.   NATURE MEDICINE

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

(2008) E. van Rooij et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA